ESR1 and breast carcinoma: RNAi screening of a subset of the identified genes in a panel of breast cancer cell lines representing different breast cancer subtypes (TNBC, HER2-amplified, and ER-positive) identified potential targets that may have broad application in enhancing TRAIL activity in breast cancer cells.